Heba Alshaker

1.0k total citations
24 papers, 733 citations indexed

About

Heba Alshaker is a scholar working on Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heba Alshaker has authored 24 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Cell Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heba Alshaker's work include Sphingolipid Metabolism and Signaling (9 papers), Microtubule and mitosis dynamics (4 papers) and Caveolin-1 and cellular processes (3 papers). Heba Alshaker is often cited by papers focused on Sphingolipid Metabolism and Signaling (9 papers), Microtubule and mitosis dynamics (4 papers) and Caveolin-1 and cellular processes (3 papers). Heba Alshaker collaborates with scholars based in United Kingdom, Jordan and United States. Heba Alshaker's co-authors include Dmitri Pchejetski, Khalid Z. Matalka, Mathias Winkler, Colin Cooper, Christopher B. White, Torsten Böhler, Shyam Srivats, Qi Wang, Yimin Chao and Adam E. Frampton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Heba Alshaker

22 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba Alshaker United Kingdom 16 487 157 149 120 110 24 733
Hong Sun China 13 440 0.9× 109 0.7× 197 1.3× 102 0.8× 90 0.8× 35 715
Shuang Yan China 17 466 1.0× 135 0.9× 215 1.4× 84 0.7× 85 0.8× 50 801
Chunbo He China 14 505 1.0× 153 1.0× 134 0.9× 298 2.5× 87 0.8× 35 886
Xiaoyi Wang China 18 549 1.1× 298 1.9× 182 1.2× 102 0.8× 120 1.1× 39 918
Kyung Hee Koo South Korea 9 487 1.0× 245 1.6× 194 1.3× 95 0.8× 64 0.6× 11 760
Eun-Jin Yun United States 16 442 0.9× 207 1.3× 138 0.9× 89 0.7× 44 0.4× 25 782
Yuyang Liu China 16 520 1.1× 263 1.7× 74 0.5× 55 0.5× 105 1.0× 29 805
Vikash Reebye United Kingdom 16 549 1.1× 184 1.2× 69 0.5× 51 0.4× 80 0.7× 36 805
Valentina Folgiero Italy 19 471 1.0× 159 1.0× 320 2.1× 97 0.8× 233 2.1× 33 970
Ignacio Niechi Chile 16 480 1.0× 202 1.3× 140 0.9× 59 0.5× 78 0.7× 29 741

Countries citing papers authored by Heba Alshaker

Since Specialization
Citations

This map shows the geographic impact of Heba Alshaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba Alshaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba Alshaker more than expected).

Fields of papers citing papers by Heba Alshaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba Alshaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba Alshaker. The network helps show where Heba Alshaker may publish in the future.

Co-authorship network of co-authors of Heba Alshaker

This figure shows the co-authorship network connecting the top 25 collaborators of Heba Alshaker. A scholar is included among the top collaborators of Heba Alshaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba Alshaker. Heba Alshaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pchejetski, Dmitri, Ewan Hunter, Jayne Green, et al.. (2023). Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection. Cancers. 15(3). 821–821. 7 indexed citations
3.
Alshaker, Heba, Ewan Hunter, Aroul Ramadass, et al.. (2022). Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells. Frontiers in Oncology. 12. 990842–990842. 3 indexed citations
4.
Alshaker, Heba, Robert Mills, Aroul Ramadass, et al.. (2021). Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups. Journal of Translational Medicine. 19(1). 46–46. 12 indexed citations
5.
Pchejetski, Dmitri, et al.. (2020). Bradycardia and syncope as sole manifestations of a cranial lesion: a case report. Journal of Medical Case Reports. 14(1). 24–24. 3 indexed citations
6.
Alshaker, Heba, et al.. (2020). Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target. Frontiers in Oncology. 10. 289–289. 24 indexed citations
7.
Alshaker, Heba, Qi Wang, Daniel Brewer, & Dmitri Pchejetski. (2019). Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting. Frontiers in Pharmacology. 10. 303–303. 22 indexed citations
8.
Alshaker, Heba, et al.. (2018). Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors. Breast Cancer Research and Treatment. 172(1). 33–43. 15 indexed citations
9.
Pchejetski, Dmitri, et al.. (2017). An unusual case of disseminated intravascular coagulation. Oxford Medical Case Reports. 2017(4). omx009–omx009.
10.
Alshaker, Heba, Qi Wang, Shyam Srivats, et al.. (2017). New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth. Breast Cancer Research and Treatment. 165(3). 531–543. 23 indexed citations
11.
Alshaker, Heba, Qi Wang, Torsten Böhler, et al.. (2017). Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1. Scientific Reports. 7(1). 3493–3493. 25 indexed citations
12.
Wang, Qi, Heba Alshaker, Torsten Böhler, et al.. (2017). Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer. Scientific Reports. 7(1). 5901–5901. 62 indexed citations
13.
Sacco, Keith, et al.. (2016). Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancer. Oncology Letters. 12(2). 779–782. 7 indexed citations
14.
Pchejetski, Dmitri, et al.. (2015). Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer. Journal of Cancer Research and Clinical Oncology. 142(8). 1659–1671. 24 indexed citations
15.
Alshaker, Heba, Jonathan Krell, Adam E. Frampton, et al.. (2014). Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Research. 16(5). 426–426. 42 indexed citations
16.
Alshaker, Heba, Qi Wang, Adam E. Frampton, et al.. (2014). Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer. Breast Cancer Research and Treatment. 149(1). 59–67. 28 indexed citations
17.
Pinho, Filipa G., Adam E. Frampton, João Nunes, et al.. (2013). Downregulation of microRNA-515-5p by the Estrogen Receptor Modulates Sphingosine Kinase 1 and Breast Cancer Cell Proliferation. Cancer Research. 73(19). 5936–5948. 67 indexed citations
18.
Alshaker, Heba, Lysann Sauer, Silvia Ottaviani, et al.. (2013). Therapeutic Potential of Targeting SK1 in Human Cancers. Advances in cancer research. 117. 143–200. 44 indexed citations
19.
Alshaker, Heba, et al.. (2011). Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time. BMC Complementary and Alternative Medicine. 11(1). 9–9. 28 indexed citations
20.
Alshaker, Heba & Khalid Z. Matalka. (2011). IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors. Cancer Cell International. 11(1). 33–33. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Sun Breakdown of academic impact, for papers by Shuang Yan Breakdown of academic impact, for papers by Chunbo He Breakdown of academic impact, for papers by Xiaoyi Wang Breakdown of academic impact, for papers by Kyung Hee Koo Breakdown of academic impact, for papers by Eun-Jin Yun Breakdown of academic impact, for papers by Yuyang Liu Breakdown of academic impact, for papers by Vikash Reebye Breakdown of academic impact, for papers by Valentina Folgiero Breakdown of academic impact, for papers by Ignacio Niechi
Rankless by CCL
2026